A transcriptomic resource for glial GABA-associated ASH neuronal aging and candidate pathways

Neuronal aging is tightly linked to neurodegeneration with dysregulation of GABA (gamma-aminobutyric acid), the primary inhibitory neurotransmitter, contributing to age-associated neuronal impairment. Our prior work demonstrated that restoring the key GABA-synthesizing enzyme UNC-25 (glutamic acid decarboxylase, GAD) in Caenorhabditis elegans AMsh glia mitigates age-related neurodegeneration. This study aims to provide a transcriptomic resource and identify potential pathways associated with glial GABA modulation during neuronal aging.

ASH neurons from day 1 and day 7 nematodes were isolated and FACS-purified (Psra-6::RFP+/Pgpa-4::GFP-) from three distinct groups: Wild-type, unc-25 mutants, unc-25 mutants with AMsh glia-specific UNC-25 rescue. RNA-seq used Illumina NovaSeq (150 bp PE reads, aligned to WormBase WS293). DESeq2 identified DEGs (FDR < 0.05, fold-change ≥ 1); clusterProfiler performed GSEA and pathway enrichment. Comparisons also included AMsh glia vs. ASH neurons in wild young adults.

Here, we present transcriptomic data of glutamatergic ASH sensory neurons (a critical target of aging-related neurodegeneration) from three aging groups: wild-type worms, unc-25 (GABA-deficient) mutants, and unc-25 mutants with AMsh glia-specific UNC-25 rescue. Transcriptomic analyses revealed distinct transcriptional profiles across groups. Notably, the Hedgehog signaling pathway and its transcriptional effector TRA-1/GLI, the C. elegans GLI ortholog, were specifically upregulated in the glial rescue group, while the neuroprotective transcription factor HSF-1 was downregulated, suggesting these pathways as potential mediators of glial GABA-associated neuroprotection. We also provide transcriptomic comparisons between AMsh glia and ASH neurons in young worms, laying a foundation for understanding glia-neuron crosstalk.

This work establishes a valuable transcriptomic resource for glial GABA-associated ASH neuronal aging and identifies candidate pathways, offering critical molecular insights to dissect age-related neurodegeneration mechanisms and inform potential therapeutic targets.